Frazier Management’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Frazier Management’s Portfolio FRLN Stock Details FRLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-36,667	Closed	-$1.88M	–	45
2021 Q3	$1.88M	Hold	36,667	–	–	0.15%	40
2021 Q2	$4.48M	Hold	36,667	–	–	0.41%	27
2021 Q1	$6.76M	Hold	36,667	–	–	0.54%	26
2020 Q4	$10M	Hold	36,667	–	–	0.77%	22
2020 Q3	$8.59M	Buy	+36,667	New	+$9.19M	0.77%	18

Other funds holding FRLN

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HCA

Harbor Capital Advisors Chicago, Illinois $1.47B AUM 42.58% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Frazier Management's FRLN Position: Q4 2021 in Review

Frazier Management sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q4 2021, closing a stake of 36,667 shares — an estimated $1.88M sold.

Frazier Management first reported a position in FRLN in Q3 2020 and held it in 5 quarters. The position peaked at $10M in Q4 2020. 18 funds tracked by Wall St. Rank hold FRLN as of Q4 2021.

Frazier Management reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
Frazier Management sold 36,667 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q4 2021, an estimated $1.88M.
Frazier Management first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2020 and held it in 5 quarters.
Frazier Management's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $10M in Q4 2020.
18 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q4 2021.

Based on Frazier Management's 13F filing for Q4 2021, filed 8 Feb 2022.